In this work, this approach is evaluated via a case study of determining the drug resistance status of M. tuberculosis by processing the data on four biochemical markers (three types of matrix proteinases and the related tissue inhibitor TIMP) obtained from the blood tests of TB-suffering patients and a control group of healthy persons. This evidence concerns the gene TIMP1 and tuberculosis.